Adalimumab therapy for refractory uveitis: A pilot study

Journal of Ocular Pharmacology and Therapeutics

Volumn 24, Issue 6, 2008, Pages 613-614

  Callejas Rubio, José Luis ^a   Sánchez Cano, Daniel ^a   Serrano, José Luis García ^a   Ortego Centeno, Norberto ^a  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CYCLOSPORIN; ETANERCEPT; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE;

ADULT; AGED; CLINICAL ARTICLE; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG TOLERABILITY; EYE INFLAMMATION; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MALE; PILOT STUDY; RELAPSE; THERAPY RESISTANCE; UVEITIS; VISUAL ACUITY;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; UVEITIS;

EID: 57349102322     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2008.0073     Document Type: Letter

References (2)

1. Díaz-Llopis, M., García-Delpech, S., Salom, D., et al. Adalimumab therapy for refractory uveitis: A pilot study. J. Ocul. Pharmacol. Ther. 24:351-361, 2008.
2. Yazici, Y., and Yazici, H. Tumor necrosis factor alpha inhibitors, methotrexate or both? An inquiry into the formal evidence for when they are to be used in rheumatoid arthritis. Clin. Exp. Rheumatol. 26:449-452, 2008.